Clinical Highlights: 15th Annual CMHC Live Online

    NEXT STORY
    Agios to Host a Webinar on its Pyruvate Kinase-R (PKR) Activation Clinical Programs and Commercial Outlook on Thursday, November 19, 2020
    PREV STORY
    Prosecutor pressed charges against a member of Orion’s Board of Directors for a suspected securities market offence – the suspected offence is not related to Orion
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Data from Multiple Celldex Programs Presented at American Association for Cancer Research (AACR) Annual Meeting 2018

    author_avatar
    NASDAQ Market News

    Orion Corporation: Disclosure under chapter 9, section 10 of the Securities Market Act: The total share of voting rights of Orion shares owned by Maa- ja vesitekniikan tuki ry and a company controlled by it, Tukinvest Oy, has exceeded 5%

    author_avatar
    NASDAQ Market News

    Roche provides update on phase III studies of etrolizumab in people with moderately to severely active ulcerative colitis

    author_avatar
    NASDAQ Market News